SEVERE SHOCK 
& MULTIPLE ORGAN DYSFUNCTION SYNDROME

Current Seminars Seminars By Date Seminars By Region Objectives Schedule Faculty

INTRODUCTION

Shock is the most frequently encountered and the most devastating complication of critical illness. Although causes of shock are multiple and varied, the syndrome invariably involves a potentially life-threatening inadequacy of perfusion to the tissues. This sets in motion a complex cascade of cellular events, often leading to multiple organ dysfunction and failure.

Designed for practicing critical care nurses, this seminar begins with an in-depth look at the cellular chaos occurring during shock. Assessment and monitoring of the patient in severe shock is discussed in detail, followed by treatment options. Evidence-based practice guidelines and current research findings are incorporated, and clinical scenarios are included to maximize practical application.

Presented by an experienced critical care nurse educator who is known for her high energy, lively approach, and ability to simplify complex concepts, this seminar provides an enjoyable educational experience for all.

A sample of the type of questions to be answered during this one-day program includes:

What hemodynamic parameters are indicative of shock?

What are the physiological differences between the shock classifications?

When does shock become severe shock?

What degree of decreased tissue perfusion is necessary to cause organ dysfunction?

What are biological mediators, and what is their relevance in shock and sepsis?

Why do organs fail in a predictable sequence?

Is organ dysfunction an inevitable consequence of shock?

What is the current consensus regarding the importance of assessing oxygen delivery and oxygen consumption in the septic patient?

Why does insulin resistance and hyperglycemia develop during shock?

What does the current research say about the importance of glucose control in the critically ill?

What is the difference between sepsis and SIRS?

How can physiological scoring systems be used to make treatment decisions and predict outcomes?

What did the PROWESS study find?

What is Drotrecogin alfa (activated) (Xigris) and why is it being used for treatment of patients with septic shock?

Why do ARDS, renal failure and DIC often occur in patients who sustain shock?

Why is it common for patients who are successfully resuscitated from a shock state to subsequently die several weeks after being resuscitated?


Severe Shock Flyer Cover


For Current Seminar
Dates and Locations


Presented by:
Carol A. Rauen,
R.N., M.S., CCNS, CCRN


 
  
CONTINUING EDUCATION CREDIT

 
  Seminar approved by:

American Association
of Critical-Care Nurses


6.0 contact hours
Category A

  Provider approved by:

California Board of
Registered Nursing

CEP 6910

 

 Copyright 1999 - 2017  BarbaraClarkMims Associates